Cargando…
RANKL Impairs the TLR4 Pathway by Increasing TRAF6 and RANK Interaction in Macrophages
High serum levels of osteoprotegerin (OPG) are found in patients with obesity, type 2 diabetes, sepsis, or septic shock and are associated with a high mortality rate in stroke. The primary known function of OPG is to bind to the receptor activator of NF-κB ligand (RANKL), and by doing so, it inhibit...
Autores principales: | Mota, Ryerson Fonseca, Cavalcanti de Araújo, Paulo Henrique, Cezine, Maria Eduarda Ramos, Matsuo, Flávia Sayuri, Metzner, Rodrigo Jair Morandi, Oliveira de Biagi Junior, Carlos Alberto, Peronni, Kamila Chagas, Hayashi, Hiroki, Shimamura, Munehisa, Nakagami, Hironori, Osako, Mariana Kiomy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019442/ https://www.ncbi.nlm.nih.gov/pubmed/35463988 http://dx.doi.org/10.1155/2022/7740079 |
Ejemplares similares
-
Decrease in Blood Pressure and Regression of Cardiovascular Complications by Angiotensin II Vaccine in Mice
por: Nakagami, Futoshi, et al.
Publicado: (2013) -
Prevention of bleomycin-induced pulmonary fibrosis by a RANKL peptide in mice
por: Ju, Nan, et al.
Publicado: (2022) -
A Novel Therapeutic Peptide as a Partial Agonist of RANKL in Ischemic Stroke
por: Kurinami, Hitomi, et al.
Publicado: (2016) -
Preventative effects of the partial RANKL peptide MHP1-AcN in a mouse model of imiquimod-induced psoriasis
por: Ju, Nan, et al.
Publicado: (2019) -
Therapeutic Effects of Systemic Administration of the Novel RANKL-Modified Peptide, MHP1, for Ischemic Stroke in Mice
por: Shimamura, Munehisa, et al.
Publicado: (2018)